Evaluation of the CareStart™ Glucose-6-phosphate dehydrogenase (G6PD) Rapid Diagnostic test at Community and Health Centers
in Cambodia
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Design
• Quasi-experimental design in Oddar Meanchay
province, Cambodia.
• Post-training, each of the 94 HCW/VMWs (age 1869yrs) performed on average 10 G6PD RDT tests on
960 adult males.
• Performance of CareStart™ RDT for G6PDd screening
was assessed against quantitative G6PD test (Pointe
Scientific, Inc. Canton MI).
• Pre/post-training questionnaires completed by
HCW/VMWs and G6PD volunteers.
Blood sample collection
• Study was conducted from Dec, 2017 to Feb, 2018.
• Finger prick blood sample was obtained for
CareStart™ RDT testing in the field.

The G6PD test results were not statistically significant
between the groups.

The distribution of G6PD enzymatic activity according to spectrophotometry ranged from 0.05 to 22.57, with
adjusted male median of 8.35 U/g Hb (100% activity).

G6PD RDT RESULTS
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Knowledge about PQ and G6PD screening

• 2ml venous blood was collected in Vacutainer tubes (BD
Vacutainer, Franklin Lakes, NJ) for CBC and quantitative
G6PD testing in lab.

The pre/post training questionnaires assessed trainee
knowledge, and perception of PQ risk and willingness
to give PQ based on G6PD status by RDT.
All scores improved post training
There was no statistical significance between the
HCWs and VMWs

Data Collection
 Demographics data was collected with questionnaires
 Perceptions on PQ risk and benefits and willingness to use
G6PD RDTs for screening was evaluated
Primary Endpoint
Assess the sensitivity, specificity, PPV and NPV of
CareStart™ RDT in the field setting vs. the quantitative G6PD
activity thresholds (“gold standard” for G6PDd diagnosis).
Survey
Questionnaire

PRETRAINING

Willingness to test for G6PD
when a patient is diagnosed
with malaria

56.3%
(53/94)

Level of comfort in giving PQ
based on G6PD RDT results

39.3%
(37/94)

72.3%
(68/94)

Level of comfort in giving PQ to
a patient with P.v and normal
G6PD test

36.1%
(34/94

80.0%
(76/94)

Percentage means scores

POSTTRAINING

80.8%
(76/94)

Willingness to give a patient PQ 20.2%
single dose for Pf without G6PD (19/94)
screening
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Scores improved post training for all education levels
(p<0.001)

Years of Experience

84%
(79/94)

100

Outcome of our study denoted
a highly sensitive test (96.8%)
with high NPV, valuable in
reducing risk when PQ is
prescribed.
With minimal training,
CareStart™ RDT is highly
specific, feasible and a
practical option for the
identification of G6PDd male
patients and its use may
enable safer prescribing of PQ
to decrease the burden from
P.v relapse.

Community engagement can have profound effect on PQ risk
perceptions and integrating short training within community
settings should be a priority with the planned deployment of
PQ.
Most trainees were very receptive to the information provided
about PQ and RDT testing, and were able to retain knowledge
acquired during training.
Though the numbers were small, some G6PDd volunteers will
be misclassified as normal and therefore, patient follow up,
monitoring and patient counseling will be paramount to
successful deployment of PQ in Cambodia.
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Scores improved post training for all levels of experience (p<0.001)

Assessing willingness and level of comfort in giving PQ based on RDT results
Willingness to give radical cure PQ to a
patient with P.v
I don’t know

Not Willing

Not comfortable
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Reference standard
• The G6PD spectrophotometric quantitative analysis was
performed using a Pointe G6PD reagent kit (Pointe
Scientific, Inc. MI, USA).

Pre-Training

Education Level

Percentage Mean Score

Analysis:
• Descriptive and inferential statistics
to evaluate the acceptability and
effectiveness of training.
• Stata 15, SPSS, and Graphprism 7.
Standard methods for calculating
sensitivity, specificity, PPV & NPV
were applied to the G6PD RDT (95%
CI)..
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The RDT test results obtained by trainees in the field were
compared against the performance of the RDT test by expert
readers both in field and laboratory settings

Training tools and G6PD
counseling script were very
effective
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• Assess CareStart™ performance in
the hands of healthcare and village
malaria workers vs. expert readers
both in field and laboratory settings
against reference lab quantitative
test (Pointe Scientific, Inc. MI).

156/960 (16%) diagnosed as G6PDd (< 2.505)

0

• Develop training materials
on G6PD and PQ to
improve knowledge and
acceptability of PQ use.

• Assess the
HCW/VMWs’
knowledge of PQ, their
acceptability to test for
G6PD using
CareStart™, and
willingness to give PQ
when the G6PD status
of the patient is known
by RDT.

CareStart™ G6PD Rapid Diagnostic Test
offered at the point-of-care will alleviate
the lack of testing for G6PDd, thereby
lowering the risk of hemolysis when PQ is
prescribed.
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Objectives

G6PD Test Results
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There is insufficient data on
performance of G6PD RDT in
field setting, and whether it
matches the performance
demonstrated in controlled lab
settings by researchers.

The G6PD RDT may enable
safer application of PQ and
reduce the burden of vivax
malaria. Malaria workers
need training on risks and
benefits of PQ, G6PD
testing and correct
interpretation of G6PD RDT
results in the field.

Conclusion

Results
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Primaquine (PQ) is the only FDA-approved drug for
radical cure of Plasmodium vivax (P.v) malaria but
treatment can result in life-threatening hemolysis if given
to a glucose-6-phosphate dehydrogenase deficient
(G6PDd) patient. Therefore, the G6PD status of the
patient with P.v must be known prior to prescribing PQ. To
increase PQ access in Cambodia, performance of G6PD
rapid diagnostic tests (RDTs) needs to be evaluated in
healthcare workers (HCWs) and village malaria workers
(VMWs).
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